Published in Neurobiol Aging on February 01, 2005
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease (NILVAD) | NCT02017340
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Mol Med (2010) 0.98
Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NEDICES). Neuroepidemiology (2009) 0.97
Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine. Biochim Biophys Acta (2011) 0.94
Calcium channel blockers and dementia. Br J Pharmacol (2013) 0.91
Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88
Dantrolene, a treatment for Alzheimer disease? Alzheimer Dis Assoc Disord (2015) 0.79
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease. BMJ Open (2014) 0.79
Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Ther Adv Chronic Dis (2015) 0.78
Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis. Exp Brain Res (2005) 0.77
A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients. Medicine (Baltimore) (2016) 0.75
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40
Statistical models for prevalent cohort data. Biometrics (1993) 3.16
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS (1987) 3.01
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol (1997) 2.43
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.36
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol (1987) 2.29
Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28
Effects of mid-point imputation on the analysis of doubly censored data. Stat Med (1992) 2.09
Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology (2003) 2.06
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 1.92
Prevalence of dementia after age 90: results from the 90+ study. Neurology (2008) 1.88
Free testosterone and risk for Alzheimer disease in older men. Neurology (2004) 1.88
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol (1995) 1.72
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
Modelling paired survival data with covariates. Biometrics (1989) 1.59
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54
Learning and retention in preclinical and early Alzheimer's disease. Psychol Aging (1997) 1.48
Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med (1986) 1.46
Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol (1989) 1.44
Age-specific norms for the Mini-Mental State Exam. Neurology (1988) 1.42
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epidemiol (1987) 1.32
Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis (1996) 1.30
Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg (1997) 1.30
Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin. J Neurol Neurosurg Psychiatry (2004) 1.27
Estimating a treatment effect from multidimensional longitudinal data. Biometrics (1998) 1.25
Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol (1998) 1.22
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology (2005) 1.17
Matched case-control designs and overmatched analyses. Am J Epidemiol (1986) 1.16
Neuropathologic features associated with Alzheimer disease diagnosis: age matters. Neurology (2011) 1.15
Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am J Epidemiol (1998) 1.14
Adult life span changes in immediate visual memory and verbal intelligence. Psychol Aging (1995) 1.13
Neuropsychological function in nondemented carriers of presenilin-1 mutations. Neurology (2005) 1.13
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging (2006) 1.11
Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol (1995) 1.09
Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn (1996) 1.09
Use of cancer controls in case-control cancer studies. Am J Epidemiol (1987) 1.06
Aging and the public health effects of dementia. N Engl J Med (2001) 1.05
Global effects estimation for multidimensional outcomes. Stat Med (2007) 1.02
Familial cancer history and chronic lymphocytic leukemia. A case-control study. Am J Epidemiol (1989) 1.01
Methods for projecting course of acquired immunodeficiency syndrome epidemic. J Natl Cancer Inst (1988) 0.99
APOE genotype and survival in men and women with Alzheimer's disease. Neurology (2002) 0.97
U.S. nephrologists' attitudes towards renal transplantation: results from a national survey. Transplantation (2001) 0.97
Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994. MMWR Recomm Rep (1992) 0.96
Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States. 1990 to 1992. Med Care (1998) 0.96
Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr (1991) 0.95
Reversible dementia with idiopathic hypereosinophilic syndrome. Neurology (1989) 0.94
Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol (1987) 0.93
The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men. Arch Intern Med (2000) 0.93
Analysis of infectious disease data from partner studies with unknown source of infection. Biometrics (1993) 0.92
Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res (1987) 0.91
Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am J Epidemiol (1987) 0.91
The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living. Gerontologist (1998) 0.90
Bivariate frailty model for the analysis of multivariate survival time. Lifetime Data Anal (1996) 0.90
Managed mental health care and patterns of inpatient utilization for treatment of affective disorders. Soc Psychiatry Psychiatr Epidemiol (1995) 0.90
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood (1985) 0.88
Covariate-dependent genetic counseling in Huntington's disease. J Neurogenet (1986) 0.87
Impaired ranking of semantic attributes in dementia. Brain Lang (1985) 0.86
Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. J Natl Cancer Inst (1986) 0.85
Case-control studies for estimation of the natural history of preclinical disease from screening data. Stat Med (1986) 0.85
The diversity of T cell receptors specific for self MHC gene products. J Immunol (1983) 0.82
Measuring HIV-1 incidence in northern Thailand: prospective cohort results and estimates based on early diagnostic tests. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.81
Age-associated changes in specific errors on the Benton Visual Retention Test. J Gerontol B Psychol Sci Soc Sci (1995) 0.81
Changes in semantic memory in early stage Alzheimer's disease patients. Gerontologist (1993) 0.81
Modeling Maternal-Infant HIV Transmission in the Presence of Breastfeeding with an Imperfect Test. Biometrics (2007) 0.80
Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. AIDS (1996) 0.79
Women and alzheimer disease. Alzheimer Dis Assoc Disord (2000) 0.79
The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res (1993) 0.79
AIDS surveillance and prediction of the HIV and AIDS epidemic: methodological developments. AIDS (1993) 0.79
Suicide and HIV infection. Mortality follow-up of 4147 HIV-seropositive military service applicants. JAMA (1996) 0.78
Energy requirements of parenterally fed bone marrow transplant recipients. JPEN J Parenter Enteral Nutr (1985) 0.78
Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection. Sex Transm Dis (1997) 0.77
More on the relation between AIDS cases and HIV prevalence. N Engl J Med (1989) 0.77
Prediction intervals for survival data. Stat Med (1984) 0.76
Systolic blood pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort. J Geriatr Psychiatry Neurol (1999) 0.76
Application of random effects models and other methods to the analysis of multidimensional quality of life data in an AIDS clinical trial. Med Care (1999) 0.75